Shares of Medicamen Biotech soared by 14.06% as of 9:39 AM, trading at ₹492.05, following the company’s announcement of securing a ₹6.28 crore order for the supply of Povidone Iodine Solution.
Key Highlights:
- Order Details: The company has received an order worth ₹6.28 crore for the delivery of Povidone Iodine Solution.
- Impact on Share Price: The announcement has sparked a significant rally in the stock, reflecting investor confidence in the company’s growing order book.
- Market Reaction: The stock opened higher and continued to gain momentum, recording a strong uptick in early trade.
This development is expected to enhance the company’s revenue and strengthen its foothold in the pharmaceutical market.
TOPICS:
Medicamen Biotech